Indefinite Delivery Contract SPE2DU25D1210

The federal contract IDV award is an Indefinite Delivery Contract (IDC) valued at $4,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, which runs through December 31, 2036, provides for the procurement of a comprehensive range of pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This IDC serves as a primary vehicle for supplying these critical medical commodities to support military healthcare programs globally, encompassing therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care.

The original solicitation covers the DLA Troop Support's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which aims to establish multiple regional primary and backup supplier contracts to provide worldwide pharmaceutical support to the Defense Health Agency, Department of Defense, U.S. Coast Guard, and other federal customers. The estimated total value for this procurement is $30.3 billion, and the contracts will have a 30-month base period with three 30-month option periods. The solicitation is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation approach.